ERSP Press Releases

ERSP Finds Farr Laboratories, Inc. Can Support Performance Claims for ‘Prosta-Q,’ Recommends Marketer Modify Certain Claims

ERSP determined that Farr Laboratories, LLC can support general performance claims for Prosta-Q, a dietary supplement intended to address the symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), but recommended certain changes.

Read More

ERSP Finds Lonza America Provided Reasonable Basis for Immune System Claims; Recommends Modification to Establishment Claims

ERSP has recommended that Lonza America, Inc., modify certain “clinically” proven claims for the company’s “Alomune” dietary supplement.

Read More

ERSP Refers Advertising for Internet Secrets to FTC for Further Review After Marketer Fails to Respond to ERSP Inquiry

ERSP will refer direct response advertising for The 7 Day Test Affiliate Marketing Program to the Federal Trade Commission (FTC) after the marketer, Internet Secrets, failed to respond to an ERSP inquiry.

Read More

ERSP Refers Advertising for Hazel Peppergood Work-at-Home System to FTC for Further Review After Marketer Fails to Respond to ERSP Inquiry

ERSP will refer direct response advertising for Hazel Peppergood Work-at-Home System to the Federal Trade Commission (FTC) after the marketer, Hazel Peppergood, Inc., failed to respond to an ERSP inquiry.

Read More

ERSP Recommends Plymouth Direct Discontinue Certain Claims for ‘Tag Away;’ Finds Marketer Can Support Safety Claims

ERSP recommended that Plymouth Direct discontinue certain performance and establishment claims made for Tag Away, a homeopathic skin tag removal drug. ERSP found, however, the marketer could support “all natural” and safety claims.

Read More

ERSP Refers Advertising for Richatlast.com to FTC for Further Review After Marketer Fails to Respond to ERSP Inquiry

ERSP will refer direct response advertising for Richatlast.com Affiliate Marketing Program to the FTC after the marketer, Richatlast.com, failed to respond to an ERSP inquiry.

Read More